Market Survey on Excimer and Femtosecond Ophthalmic Lasers Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment 2022 to 2032

<p>The global <strong>Excimer and Femtosecond Ophthalmic Lasers Market </strong>size reached <strong>US$ 1.02 billion</strong> in 2021 and is expected to touch a valuation of <strong>US$ 1.18 billion</strong> by the end of 2022. Furthermore, with the increasing prevalence of eye diseases across the world and growing adoption of ophthalmic lasers, the overall sales of excimer and femtosecond ophthalmic lasers are projected to rise at <strong>8.0% CAGR</strong> over the forecast period (2022 to 2032), totaling a market valuation of <strong>US$ 2.41 billion</strong> by 2032.</p><table><tbody><tr><th scope='row'>Attribute</th><td>Key Statistics</td></tr><tr><th scope='row'>Excimer and Femtosecond Ophthalmic Lasers Market Base Value (2021)</th><td>US$ 1.02 billion</td></tr><tr><th scope='row'>Estimated Market Value (2022)</th><td>US$ 1.18 billion</td></tr><tr><th scope='row'>Projected Market Value (2032)</th><td>US$ 2.41 billion</td></tr><tr><th scope='row'>Value-based CAGR of (2022 to 2032)</th><td>8.0%</td></tr><tr><th scope='row'>Market share of Top 5 countries</th><td>56.5%</td></tr></tbody></table><p>Report Scope</p><table><tbody><tr><th scope='row'>Attribute</th><td>Details</td></tr><tr><th scope='row'>Estimated Market Size (2022)</th><td>US$ 1.18 billion</td></tr><tr><th scope='row'>Projected Market Size (2032)</th><td>US$ 2.41 billion</td></tr><tr><th scope='row'>Anticipated Growth Rate (2022 to 2032)</th><td>8.0% CAGR</td></tr><tr><th scope='row'>Forecast Period</th><td>2022 to 2032</td></tr><tr><th scope='row'>Historical Data Available for</th><td>2014 to 2021</td></tr><tr><th scope='row'>Market Analysis</th><td>US$ Million for Value</td></tr><tr><th scope='row'>Key Regions Covered</th><td>North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East &amp; Africa (MEA).</td></tr><tr><th scope='row'>Key Countries Covered</th><td>The USA, Canada, Brazil, Mexico, Argentina, The Rest of Latin America, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, The Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Australia, New Zealand, Turkey, GCC, South Africa, Israel, North Africa and Rest of MEA.</td></tr><tr><th scope='row'>Key Market Segments Covered</th><td>Product, application, end user, region</td></tr><tr><th scope='row'>Key Companies Profiled</th><td>Medtronic Public Limited Company, Boston Scientific Corp, St Jude Medical LLC and Nevro Corp, Nuvectra Corporation and Stimwave, Neurosigma Inc., Synapse Biomedical Inc., Abbott Laboratories, Beijing PINS Medical Co., Ltd, Cirtec Medical Corporation, Gimer Medical, Bluewind Medical, Bioinduction, Greatbatch, Inc., Saluda Medical Pty Ltd.</td></tr><tr><th scope='row'>Report Coverage</th><td>Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives</td></tr></tbody></table>

<p>全球<em>准分子及飞秒激光眼科市场</em>规模于2021年达到<em>10.2亿美元</em>，预计至2022年底将达到<em>11.8亿美元</em>的估值。此外，随着全球范围内眼科疾病发病率的上升以及眼科激光应用的日益普及，预计准分子及飞秒激光眼科激光器的整体销售额将在预测期内（2022年至2032年）以<em>8.0%的复合年增长率</em>增长，到2032年市场估值将达到<em>24.1亿美元</em>。</p><table><tbody><tr><th scope='row'>属性</th><td>关键统计数据</td></tr><tr><th scope='row'>准分子及飞秒激光眼科市场基础价值（2021年）</th><td>10.2亿美元</td></tr><tr><th scope='row'>预计市场价值（2022年）</th><td>11.8亿美元</td></tr><tr><th scope='row'>预计市场价值（2032年）</th><td>24.1亿美元</td></tr><tr><th scope='row'>基于价值的复合年增长率（2022年至2032年）</th><td>8.0%</td></tr><tr><th scope='row'>前五国的市场份额</th><td>56.5%</td></tr></tbody></table><p>报告范围</p><table><tbody><tr><th scope='row'>属性</th><td>详情</td></tr><tr><th scope='row'>预计市场规模（2022年）</th><td>11.8亿美元</td></tr><tr><th scope='row'>预计市场规模（2032年）</th><td>24.1亿美元</td></tr><tr><th scope='row'>预期增长率（2022年至2032年）</th><td>8.0% CAGR</td></tr><tr><th scope='row'>预测期</th><td>2022年至2032年</td></tr><tr><th scope='row'>可提供历史数据年份</th><td>2014年至2021年</td></tr><tr><th scope='row'>市场分析</th><td>按价值计算（百万美元）</td></tr><tr><th scope='row'>涵盖的关键地区</th><td>北美、拉丁美洲、欧洲、东亚、南亚、大洋洲和中东及非洲（MEA）。</td></tr><tr><th scope='row'>涵盖的关键国家</th><td>美国、加拿大、巴西、墨西哥、阿根廷、拉丁美洲其他地区、英国、德国、意大利、俄罗斯、西班牙、法国、BENELUX、欧洲其他地区、日本、中国、韩国、印度、泰国、印度尼西亚、马来西亚、越南、菲律宾、澳大利亚、新西兰、土耳其、GCC、南非、以色列、北非和MEA其他地区。</td></tr><tr><th scope='row'>涵盖的关键市场细分</th><td>产品、应用、最终用户、地区</td></tr><tr><th scope='row'>介绍的关键公司</th><td>美敦力公共有限公司、波士顿科学公司、圣犹达医疗公司、Nevro公司、Nuvectra公司、Stimwave公司、Neurosigma公司、Synapse Biomedical公司、雅培实验室、北京品安医疗有限公司、Cirtec医疗公司、Gimer医疗、Bluewind医疗、Bioinduction、Greatbatch公司、Saluda医疗有限公司。</td></tr><tr><th scope='row'>报告覆盖范围</th><td>市场预测、公司份额分析、竞争情报、DROT分析、市场动态与挑战、以及战略增长举措</td></tr></tbody></table>